share_log

Heart Test Laboratories | UPLOAD: Others

Heart Test Laboratories | UPLOAD: Others

Heart Test Laboratories | UPLOAD:其他
美股SEC公告 ·  03/11 12:58
Moomoo AI 已提取核心信息
Heart Test Laboratories, Inc., a company listed in the United States under the stock code HSCS.US, has been informed by the Securities and Exchange Commission (SEC) that its Registration Statement on Form S-1, filed on March 5, 2024, will not undergo review by the commission. The SEC's communication, dated March 11, 2024, was addressed to Andrew Simpson, the Chief Executive Officer of Heart Test Laboratories. The SEC's letter also referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Additionally, the SEC reminded the company and its management of their responsibility to ensure the accuracy and adequacy of their disclosures, regardless of the SEC's level of review or lack thereof. For further inquiries, the SEC has provided contact information for Benjamin Richie.
Heart Test Laboratories, Inc., a company listed in the United States under the stock code HSCS.US, has been informed by the Securities and Exchange Commission (SEC) that its Registration Statement on Form S-1, filed on March 5, 2024, will not undergo review by the commission. The SEC's communication, dated March 11, 2024, was addressed to Andrew Simpson, the Chief Executive Officer of Heart Test Laboratories. The SEC's letter also referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Additionally, the SEC reminded the company and its management of their responsibility to ensure the accuracy and adequacy of their disclosures, regardless of the SEC's level of review or lack thereof. For further inquiries, the SEC has provided contact information for Benjamin Richie.
美国证券交易委员会(SEC)已通知Heart Test Laboratories, Inc.,一家在美国上市的公司,股票代码为HSCS.US。,该公司于2024年3月5日提交的S-1表格注册声明将不接受该委员会的审查。美国证券交易委员会于2024年3月11日发给心脏测试实验室首席执行官安德鲁·辛普森的来文。美国证券交易委员会的信中还提到了与加快注册程序的请求有关的第460和461条。此外,美国证券交易委员会提醒该公司及其管理层,无论美国证券交易委员会的审查水平如何,他们都有责任确保披露的准确性和充分性。为了进一步调查,美国证券交易委员会提供了本杰明·里奇的联系信息。
美国证券交易委员会(SEC)已通知Heart Test Laboratories, Inc.,一家在美国上市的公司,股票代码为HSCS.US。,该公司于2024年3月5日提交的S-1表格注册声明将不接受该委员会的审查。美国证券交易委员会于2024年3月11日发给心脏测试实验室首席执行官安德鲁·辛普森的来文。美国证券交易委员会的信中还提到了与加快注册程序的请求有关的第460和461条。此外,美国证券交易委员会提醒该公司及其管理层,无论美国证券交易委员会的审查水平如何,他们都有责任确保披露的准确性和充分性。为了进一步调查,美国证券交易委员会提供了本杰明·里奇的联系信息。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息